Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease
View ORCID ProfileRunhao Li, View ORCID ProfileSaifei Liu, View ORCID ProfileKenny Yeo, View ORCID ProfileSuzanne Edwards, View ORCID ProfileMan Ying Li, View ORCID ProfileRyan Santos, View ORCID ProfileSima Kianpour Rad, View ORCID ProfileFangmeinuo Wu, View ORCID ProfileGuy Maddern, View ORCID ProfileJoanne Young, View ORCID ProfileYoko Tomita, View ORCID ProfileAmanda Townsend, View ORCID ProfileKevin Fenix, View ORCID ProfileEhud Hauben, View ORCID ProfileTimothy Price, View ORCID ProfileEric Smith
doi: https://doi.org/10.1101/2024.03.14.24304260
Runhao Li
1Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
Saifei Liu
1Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
Kenny Yeo
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
3Discipline of Surgery, The University of Adelaide, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
Suzanne Edwards
6School of Public Health, The University of Adelaide, Adelaide, South Australia, 5005, Australia
Man Ying Li
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
3Discipline of Surgery, The University of Adelaide, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
Ryan Santos
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
5Viral Immunology Group, The University of Adelaide and Basil Hetzel Institute for Translational Health Research, South Australia, 5011, Australia
Sima Kianpour Rad
1Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
Fangmeinuo Wu
1Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
Guy Maddern
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
3Discipline of Surgery, The University of Adelaide, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
Joanne Young
1Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
4Medical Oncology, The Queen Elizabeth Hospital, South Australia, 5011, Australia
Yoko Tomita
1Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
4Medical Oncology, The Queen Elizabeth Hospital, South Australia, 5011, Australia
Amanda Townsend
1Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
4Medical Oncology, The Queen Elizabeth Hospital, South Australia, 5011, Australia
Kevin Fenix
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
3Discipline of Surgery, The University of Adelaide, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
Ehud Hauben
3Discipline of Surgery, The University of Adelaide, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
Timothy Price
1Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
4Medical Oncology, The Queen Elizabeth Hospital, South Australia, 5011, Australia
Eric Smith
1Solid Tumour Group, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
2Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, 5005, Australia
3Discipline of Surgery, The University of Adelaide, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia
4Medical Oncology, The Queen Elizabeth Hospital, South Australia, 5011, Australia

Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Posted March 15, 2024.
Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease
Runhao Li, Saifei Liu, Kenny Yeo, Suzanne Edwards, Man Ying Li, Ryan Santos, Sima Kianpour Rad, Fangmeinuo Wu, Guy Maddern, Joanne Young, Yoko Tomita, Amanda Townsend, Kevin Fenix, Ehud Hauben, Timothy Price, Eric Smith
medRxiv 2024.03.14.24304260; doi: https://doi.org/10.1101/2024.03.14.24304260
Circulating SFRP5 levels are elevated in colorectal cancer and correlate with overall survival in stage II-III disease
Runhao Li, Saifei Liu, Kenny Yeo, Suzanne Edwards, Man Ying Li, Ryan Santos, Sima Kianpour Rad, Fangmeinuo Wu, Guy Maddern, Joanne Young, Yoko Tomita, Amanda Townsend, Kevin Fenix, Ehud Hauben, Timothy Price, Eric Smith
medRxiv 2024.03.14.24304260; doi: https://doi.org/10.1101/2024.03.14.24304260
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)